31.6 C
Vientiane
Thursday, September 11, 2025
spot_img
Home Blog Page 22

NAVER D2SF Invests in Podonos, a Voice AI Model Evaluation Startup Based in North America

– Amid the rapid proliferation of AI models, Podonos addresses growing demand for performance evaluation and validation, especially in the voice AI domain

– Provides comprehensive testing of pronunciation, emotion, noise tolerance, and persona alignment for both AI model developers and service providers

– NAVER D2SF continues strategic investments in “AI for AI” tools across the full AI value chain

SEONGNAM, South Korea, Sept. 10, 2025 /PRNewswire/ — NAVER D2SF announced a new investment in Podonos, a North America–based startup specializing in voice AI model evaluation and benchmarking. This pre-seed round, led by U.S.-based Serac Ventures, marks Podonos’s first institutional funding, with NAVER D2SF and KAIST Venture Investment Holdings also participating from Korea.

[IMAGE] NAVER D2SF Invests in Podonos, a Voice AI Model Evaluation Startup Based in North America
[IMAGE] NAVER D2SF Invests in Podonos, a Voice AI Model Evaluation Startup Based in North America

As the number of AI models continues to surge, the need for robust evaluation and verification tools has become increasingly critical. Voice AI, in particular, is gaining rapid adoption in applications such as speech recognition, synthesis, customer service, and media content—and is emerging as a key interface for AI agents. Given the complexity of human speech, performance criteria now extend beyond pronunciation accuracy to include tone, emotion, noise resilience, persona consistency, and user preferences, increasing the demand for tailored model evaluation.

Podonos offers a unique solution by combining a global network of over 150,000 evaluators with its proprietary AI-driven automation engine, delivering voice AI model assessment results within 12 hours. Its platform serves a wide range of clients across the AI value chain, enabling AI model developers to verify, benchmark, and improve their models’ performance, while allowing service providers that leverage AI technologies to identify and monitor models that best align with their specific goals, target audiences, and operational environments.

The company’s evaluation platform is already trusted by notable voice AI startups including Resemble AI, Play AI, and Sanas AI, and has been cited by major tech media and developer communities. Podonos plans to further expand into high-demand sectors such as healthcare, finance, gaming, and advertising, while broadening its capabilities to include multimodal model evaluation.

Yang Sang-hwan, Leader of NAVER D2SF, stated, “As we enter a phase of AI abundance, the importance of ‘AI for AI’—tools that make AI more usable and reliable—is growing. Podonos is one of the few teams globally capable of quantifying and validating the performance of voice AI models. We believe they will play a key role in shaping the global voice AI landscape, with strong potential for synergy with NAVER’s own initiatives.”

Soo-hyun Bae, CEO of Podonos, added, “With this funding, we plan to accelerate hiring and enhance our automated model analysis tools. We look forward to collaborating with NAVER D2SF to deliver higher-quality voice services and grow together.”

NAVER D2SF has consistently invested in “AI for AI” technologies, including startups like Crowdworks, which focuses on AI training data generation, and Nota, which optimizes AI models for edge environments. NAVER D2SF plans to continue making strategic investments across the entire AI development value chain. 

About NAVER

Founded in 1999, NAVER is Korea’s largest Internet company and one of the world’s top tech companies. Leading cutting-edge technologies, NAVER operates No.1 search engine in Korea and holds various business portfolios encompassing commerce, fintech, cloud, AI and robotics, as well as other global online services such as LINE mobile messenger, Webtoon and Webnovel publishing, SNOW video camera app and ZEPETO metaverse platform.

NAVER recorded sales of KRW 10.74 trillion (USD 7.5 billion) in 2024. The company invests approximately 25% of its annual sales on R&D projects, pursuing innovation through continuous research and development of future technologies, such as in robotics, autonomous driving, digital twins, AI, and AR. TEAM NAVER strengthens business portfolios and expands its service regions, including Japan, North America, and Europe.

To learn more, visit www.navercorp.com/en 

Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces it has dosed the first patient in a Phase 3 clinical trial aimed at expanding the indications for Illuccix® and Gozellix® (kits for the preparation of gallium-68 (68Ga) gozetotide injection) to include prostate cancer diagnosis.

BiPASS™ (Biopsy of the Prostate Avoidance Stratification Study[1]) is the first registration-enabling study to evaluate whether the combination of MRI[2] and PSMA-PET[3] imaging can improve sensitivity, specificity, and positive and negative predictive values in diagnosing prostate cancer. The aim of the study is to demonstrate that some patients can be effectively stratified to either avoid a biopsy altogether or undergo a single PSMA-PET guided biopsy instead. Telix plans to enrol 204 patients in Australia and the United States (U.S.) for the single arm, multicenter, prospective, open label, longitudinal Phase 3 study.

The first BiPASS™ patient was dosed under the supervision of Principal Investigator Professor Tony Costello AM at the Australian Prostate Centre (APC), and imaged by Professor Rodney Hicks AM, at the Melbourne Theranostic Innovation Centre (MTIC). The first patient biopsy was performed by BiPASS™ Investigator and Clinical Director at APC, Mr. Phil Dundee.

Prof. Costello, Founder and Director, APC said, “Urologists are often faced with the dilemma of whether or not to biopsy. This invasive and often painful procedure carries risks, with many men refusing it altogether. From a clinical perspective, when the biopsy shows low to intermediate risk cancer, it’s unclear whether this represents the true burden of disease or sampling error. Combining MRI and PSMA-PET imaging has the potential to improve both the patient experience and diagnostic accuracy. As such, being part of this study is very important to the APC and our patients.”

Prof. Hicks, Founder, Chair and Chief Medical Officer, MTIC added, “PSMA-PET plus MRI has the potential to fundamentally change prostate cancer diagnosis. Using existing technologies with proven performance in lesion detection at the start of the patient journey could improve the way we stratify patients – safely de-escalating treatment or using a single precision biopsy for diagnosis.”

In the current diagnosis pathway, men with elevated PSA[4] values can be recommended for MRIs which are often inconclusive. A prostate template biopsy, which typically involves 12 – 20 needle biopsies, is commonly the next step, even in patients deemed as low risk on MRI. However, this non-specific procedure can still miss significant prostate cancer, and can be painful and subject to complications, with many found to be unnecessary. While more than 1 million biopsies are performed in the U.S. each year, up to 75% are negative[5]. Moreover, one in four patients refuse a recommended biopsy[6].

Adding an indication for prostate cancer diagnosis has the potential to significantly expand the U.S. market for Telix’s twin commercial PSMA-PET imaging agents by approximately 800,000 scans[7].

BiPASS™ builds on a promising body of research, including the PRIMARY[8]. and PRIMARY2[9] studies, which demonstrated the advantages of MRI + PSMA-PET imaging in defining or ruling out prostate cancer, or in recommending participants undergo active surveillance before an invasive biopsy is performed. Professor Louise Emmett, Principal Investigator for PRIMARY, will continue her pioneering work as a BiPASS™ Steering Committee member and an Investigator on the study.  

Prof. Emmett, Director of Theranostics and Nuclear Medicine, St Vincent’s Hospital, said, “My colleagues and I have built a significant body of research on the benefits of PSMA-PET and MRI, documented in the PRIMARY studies and we are pleased to see Telix expand on this research with this registration-enabling study. BiPASS™ has the potential to positively impact all men by changing clinical practice and guidelines to facilitate earlier, more accurate prostate cancer diagnosis.” 

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Illuccix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple markets globally. Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection) has been approved by the U.S. FDA[10].

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedInX and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

Telix Investor Relations (U.S.)  

Annie Kasparian 
Telix Pharmaceuticals Limited 
Director Investor Relations and Corporate Communications 
Email: annie.kasparian@telixpharma.com 

Media Contact

Eliza Schleifstein
917.763.8106 (Mobile)
Eliza@schleifsteinpr.com

Legal Notices 

Cautionary Statement Regarding Forward-Looking Statements  

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.  

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.  

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.  

Trademarks and Trade Names

All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.  

©2025 Telix Pharmaceuticals Limited. All rights reserved. 

[1] ClinicalTrials.gov ID: NCT07052214.
[2] Magnetic resonance imaging.
[3] Imaging of prostate-specific membrane antigen with positron emission tomography.
[4] Prostate-specific antigen.
[5] Vickers et al. J Clin Oncol. 2010.
[6] Schaufler C et al. Urologic Oncology: Seminars and Original Investigations. 2022.
[7] Based on positive scans for PI-RADS (Prostate Imaging Reporting and Data system) scores 2-4 (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer V.2.2025), includes negative scans at a ratio of 3.1 scans per positive case (Landa et al. PLOS ONE. 2024).
[8] Emmett et al., Eur Urol. 2021.
[9] ClinicalTrials.gov ID: NCT05154162. Sponsor: Peter MacCallum Cancer Centre, Australia.
[10] Telix ASX disclosure 21 March 2025.

 

Allianz Partners appoints Okan Özdemir as its new Chief Officer for Health

AUCKLAND, New Zealand, Sept. 10, 2025 /PRNewswire/ — Allianz Partners, a global leader in insurance and assistance services, is pleased to announce the appointment of Okan Özdemir as its new Chief Officer for Health and Board Member, effective September 1, 2025. In this role, Okan will report directly to Allianz Partners CEO Tomas Kunzmann

Okan Özdemir joins Allianz Partners from Allianz Türkiye, where he served as Chief Health Officer and Executive Board Member since 2019. With over 24 years of strong leadership at Allianz in a number of strategic roles including Chief Marketing Officer, he has been instrumental in advancing the company’s market leadership and growth in health insurance while overseeing a significant digital transformation within the business. 

Okan holds a degree in Business Administration from Istanbul University and a Master’s degree in Business from the European School of Management and Technology.

In his new global position, Okan will continue to strengthen Allianz Partners’ health line of business and health portfolio worldwide, while expanding its market leadership in the global health segment.

Okan Özdemir will succeed Ida Luka-Lognoné, who has led the Health business since 2015, overseeing significant growth and expansion, including developing new customer segments and expanding global operations. Ida has had a successful career spanning 30 years at Allianz Group, the last ten years of which at Allianz Partners where she played a key role in transforming the Health business into a global leader in innovative health solutions. Her leadership was instrumental in creating a culture of customer-centricity and driving strategic initiatives that positioned Allianz Partners at the forefront of the industry.

Tomas Kunzmann, CEO of Allianz Partners, commented: “We are pleased to welcome Okan as our new Chief Officer for Health, following Ida Luka-Lognoné who has made a lasting impact on our organization. Okan’s deep know-how in Health as well as his experience in digital transformation will serve well in the further expansion of the Health business and it reflects Allianz Partners’ strong momentum and our ambition to double revenues by 2030. Health remains a critical pillar of our growth strategy, and I am confident that under his leadership, we will continue to introduce innovative solutions that deliver value and peace of mind to millions of customers worldwide.” 

Kevin Blyth, MD of Allianz Partners NZ, commented: “I’m excited for Okan’s new global leadership role. While health isn’t yet part of our local market in New Zealand, his expertise will strengthen Allianz Partners’ global offerings. Ida’s support and expertise, particularly with our New Zealand student business, was invaluable. Strong leadership at the Group level ensures our customers and partners here continue to benefit from Allianz’s renowned innovation and focus”.

About Allianz Partners   

Allianz Partners is a world leader in B2B2C insurance and assistance, offering global solutions that span travel insurance, mobility, assistance, health insurance and employee benefits. Customer driven, our innovative experts are redefining insurance services by delivering future-ready, high-tech high-touch products and solutions that go beyond traditional insurance. Our products are embedded seamlessly into our partners’ businesses, sold through intermediary channels or directly to customers through the Allianz brand. Present in over 73 countries, our 22,600 employees speak 70 languages, handle over 95 million cases each year, and are motivated to go the extra mile to offer peace of mind to our customers around the world.    

For more information, please visit: www.allianz-partners.com  

About Allianz Partners New Zealand

Based in Auckland, specialising locally in providing and managing assistance services, travel insurance, student insurance and pet insurance through our New Zealand and international business partners. Our strength lies in combining the solidarity and trust that comes with being part of an established global organisation with the local expertise of our New Zealand team.

For more local information, please visit: http://www.allianzpartners.co.nz

Social media 

Follow us on X @AllianzPartners  

Follow us on LinkedIn Allianz Partners  

Follow us on LinkedIn Allianz Partners New Zealand

Follow us on YouTube /allianzpartners  

Follow us on Instagram @allianzpartners 

 

Neusoft Shares Insights and Showcases Latest Products on Consumer Experience Innovations at IAA MOBILITY 2025

MUNICH, Sept. 10, 2025 /PRNewswire/ — Neusoft Corporation (SSE: 600718), an industry-leading information technology, products and solutions company for the global market participated in IAA MOBILITY 2025, sharing insights on consumer experience innovations from China and showcasing its innovative automotive products, solutions and services designed to bring exceptional experience to consumers in the AI era, and to further transform the future of mobility.

Dr. Angela Wang, SVP of Neusoft Corporation, Chairwoman & President of Neusoft Europe, will deliver a keynote speech titled “The Inspirations from the Dynamic Consumer Experience Innovations in China for Future New Mobility” at the Main Stage of IAA Conference on September 11th, where she will share the latest trends and extensive practice of consumer experience innovations in China, and also analyze the driving forces behind the dynamics, hoping to bring inspirations to global partners and clients to accelerate innovations in both China and global markets. She will also share her insights on today’s global competition, which is more about the balance between innovation, speed and cost, and requires a new global perspective and cross-market collaborations for future new mobility.

At the exhibition, Neusoft demonstrated its most recent and innovative technological advancements and proven expertise. Among the products showcased, OneCoreGo® Global In-Vehicle Intelligent Mobility Solution 6.0 creates a brand-new global intelligent mobility experience by seamlessly integrating five core systems: One Map (Global Navigation Product Family), One Sight (AR For Car), One Store (Global In-vehicle App Ecosystem), One Pay (In-vehicle Payment Center) and One Mate (AI Interaction Center). The NAGIC Cockpit Software Platform empowers automakers to accelerate SDV transformation with agile development, cost efficiency, innovative software and flexible business models. In addition, Neusoft delivers full-stack software engineering services across domains such as CDC, CCU, ZCU, BCM, HVAC, Gateway, ECU, UX/UI, Testing, etc.

Among these innovations, One Sight (AR For Car) software product emerges as the key attraction to exhibit visitors. Powered by multiple patented AR core algorithms and a proprietary high-performance graphics engine, the product not only enhances driving safety but also creates an immersive intelligent experience through innovative integration of virtual image and reality. It transforms human-vehicle interaction from mere functionality to an emotional, engaging connection, propelling the AR-HUD user experience in vehicle to a new level.

As a technology and innovation partner for SDVs, Neusoft has more than 30 years of R&D experience in automotive software,with a global R&D and delivery network centered in China, Germany, USA, Japan and Malaysia, and more than 6,000 automotive software engineers. Neusoft automotive products have been applied to more than 1,800 vehicle models running across over 110 countries and regions, serving for more than 50 automakers.

Looking ahead, Neusoft remains deeply committed to joining hands with global partners and clients, proactively pioneering more consumer experience innovations, promoting the sustainable development of intelligent vehicles towards a safer, smarter and more customer-centric future of mobility.

For more information about Neusoft, please visit www.neusoft.com.

Jianpu Technology Inc. Announces Appointment of New Chief Financial Officer

BEIJING, Sept. 10, 2025 /PRNewswire/ — Jianpu Technology Inc. (“Jianpu,” or the “Company”) (OTCQB: AIJTY), a leading open financial technology platform in China, today announced the appointment of Ms. Xun (Amy) Zhang as the new chief financial officer of the Company, effective August 1, 2025.

Ms. Zhang has over fifteen years of financial management experience, having held senior financial positions at multinational corporations and high-growth enterprises, including ByteDance, Alibaba, Guazi, and LightInTheBox. She is well-versed in both Chinese and international financial regulations and standards and has deep insights into the technology and financial services industries. She is a U.S. Certified Public Accountant (CPA-Inactive Status) and a Certified Management Accountant (CMA).

“Ms. Zhang will play a pivotal role in enhancing the Company’s governance practices, fostering organizational alignment, driving the integration of business, finance and strategy, and strengthening the Company’s positioning in the capital markets. Her appointment underscores our continued commitment to delivering sustainable, long-term value for our customers and shareholders,” said Mr. David Ye, Co-founder, Chairman and Chief Executive Officer of Jianpu Technology.

As a fintech trailblazer, Jianpu finds itself at a pivotal moment—one where the industry is poised to embrace AI, deepen digitalization, and expand globally, while the company navigates its own industrial transformation and organizational strategic upgrade. Against this backdrop, Jianpu’s efforts to bring in versatile top-tier talent not only boost strategic alignment but also serve as a key step to solidify its path toward sustainable long-term growth.

About Jianpu Technology Inc.

Jianpu Technology Inc. operates a leading open financial technology platform, under the Rong360 brand, connecting users with an extensive spectrum of financial products and other products and services. By leveraging cutting-edge digital technology, the Company offers intelligent and comprehensive search and recommendation results in a seamless, efficient, and secure manner to meet the needs of its diverse audience. The Company also enables financial and non-financial partners to enhance their efficiency and competitiveness by offering digital intelligence as a service, including data- and analytical-based risk management, intelligent marketing, and other integrated solutions and services. As the Company expands into FinTech+ ecosystem and broadens its global footprint, it will continue to innovate and solidify its influence in the space of financial technology and digital transformation. For more information, please visit InvestorRoom – IR Home.

 

NaaS Technology Inc. to Hold Annual General Meeting on October 10, 2025

BEIJING, Sept. 10, 2025 /PRNewswire/ — NaaS Technology Inc. (Nasdaq: NAAS) (“NaaS” or the “Company”), the first U.S.-listed EV charging service company in China, today announced that it will hold an annual general meeting of shareholders (the “AGM”) at 03:00 PM Beijing time on October 10, 2025 at Conference Room 5, 2/F Arcadia International Hotel, No. 83 Xiangyun Road, Developing Area, Langfang City, Hebei Province, People’s Republic of China, for the purposes of considering and, if thought fit, passing each of the proposed resolutions set forth in the notice of the AGM (the “AGM Notice”). The AGM Notice, which contains details of these proposed resolutions, and the form of proxy cards for the AGM are available on the Company’s investor relations website at https://ir.enaas.com and are also being furnished today on a Form 6-K to the U.S. Securities and Exchange Commission (“SEC”). The Board of Directors of the Company fully supports the proposed resolutions set out in the AGM Notice and recommends that shareholders and holders of the Company’s American depositary shares (“ADSs”) vote in favor of these resolutions.

Holders of record of the Company’s ordinary shares at the close of business on September 9, 2025 (Cayman Islands time) are entitled to attend and vote at the AGM and any adjournment or postponement thereof. Holders of the ADSs at the close of business on September 9, 2025 (New York City time) who wish to exercise their voting rights for the underlying Class A ordinary shares must act through the depositary of the Company’s ADS program, JPMorgan Chase Bank, N.A.

Shareholders and ADS holders may access the Company’s public filings free of charge at the Company’s investor relations website https://ir.enaas.com, and on the SEC’s website http://www.sec.gov.

About NaaS Technology Inc.

NaaS Technology Inc. is the first U.S. listed EV charging service company in China. The Company is a subsidiary of Newlinks Technology Limited, a leading energy digitalization group in China. The Company is one of the leading providers of new energy asset operation services. The Company utilizes advanced technology to intelligently match charging supply with demand, offering electric vehicle users a seamless, efficient, and smart charging experience. Furthermore, NaaS empowers charging stations and charging station operators to optimize their operations, driving greater efficiency and enhancing profitability.

Safe Harbor Statement

This press release contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as “will,” “expects,” “believes,” “anticipates,” “intends,” “estimates” and similar statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the Company and the industry. All information provided in this press release is as of the date hereof, and the Company undertakes no obligation to update any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NaaS’ goals and strategies; its future business development, financial conditions and results of operations; its ability to continuously develop new technology, services and products and keep up with changes in the industries in which it operates; growth of China’s EV charging industry and EV charging service industry and NaaS’ future business development; demand for and market acceptance of NaaS’ products and services; NaaS’ ability to protect and enforce its intellectual property rights; NaaS’ ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China trade war and its effect on NaaS’ operation, fluctuations of the RMB exchange rate, and NaaS’ ability to obtain adequate financing for its planned capital expenditure requirements; NaaS’ relationships with end-users, customers, suppliers and other business partners; competition in the industry; relevant government policies and regulations related to the industry; and fluctuations in general economic and business conditions in China and globally. Further information regarding these and other risks is included in NaaS’ filings with the SEC.

For investor and media inquiries, please contact:

Investor Relations
NaaS Technology Inc.
E-mail: ir@enaas.com 

Media inquiries:
E-mail: pr@enaas.com 

Say Hello to Baseus PicoGo II Series: Faster, Smaller, and Safer

LAS VEGAS, Sept. 10, 2025 /PRNewswire/ — Baseus originates from the core value “Based on User”. This represents a commitment to making products that simplify the lives of users and focus on unique lifestyle needs. Baseus is committed to creating minimalist, innovative, and versatile designs filled with passion and user-centric values. Today, Baseus is excited to announce the launch of the PicoGo II Series, a charging collection built to redefine Faster. Smaller. Safer.

Baseus Picogo II Series
Baseus Picogo II Series

This new range includes versatile, powerful, and pocket-friendly charging devices suited to the tech-savvy professional, student, or simple commuter. These products are built to last longer and do more, from anywhere and at any time.

Hero Lineup

The Baseus PicoGo II Series introduces three new wall chargers and an expanded lineup of Qi2.2-certified magnetic products.

  • PicoGo AE11 Fast Charger 2C+1A 67W — one of the smallest 67W GaN chargers in the industry.
  • PicoGo AN13 Fast Charger 2C 45W — ultra-compact and optimized for dual-device fast charging.
  • PicoGo AE21 Digital Display Fast Charger 2C+1A 100W — the most portable 100W three-port GaN charger, featuring a real-time charging display.
  • Qi2.2 Magnetic Range — including the PicoGo AM61 Magnetic Power Bank 10000mAh 45W (with built-in USB-C cable), the PicoGo AF21 Foldable 3-in-1 Wireless Charger 35W, and the PicoGo AM52 Ultra-Slim Magnetic Power Bank 10000mAh 45W.

Together, these innovations deliver on the PicoGo Series’ commitment to Faster. Smaller. Safer.

PicoGo AE11 Fast Charger 2C+1A 67W

Fast Charging for Multiple Devices: The PicoGo AE11 delivers 67W via 2 USB-C ports with intelligent dynamic power distribution, allowing full-speed simultaneous charging for up to three devices. The USB-A port provides standard charging for additional devices. The charger supports mainstream fast-charging protocols, including UFCS, SCP 22.5W, and PD 3.0, making it compatible with laptops, smartphones, tablets, and other smaller electronics.

Compact and Portable: The PicoGo AE11 is one of the smallest chargers in the industry and features an ultra-compact design and foldable plug(US version) for convenient storage. This makes it ideal for traveling.

Safer Charging: Certified by TUV Rheinland, the PicoGo AE11 uses high-quality PI chips and core components from leading international manufacturers to ensure safe and compatible charging. It also offers the prevention of overcharging.

Smart Temperature Control: With Baseus’ proprietary BCT 2.0 temperature control system that uses lower heat vents and graphene materials, the PicoGo AE11 keeps your charger cool, even during extended use.

PicoGo AN13 Fast Charger 2C 45W

45W Dual Fast Charging: With a full-load 45W maximum output, the PicoGo AN13 Fast Charger ensures dynamic distribution across its dual USB-C ports. Each port supports up to 45W, allowing simultaneous fast charging for both iPhone and Samsung devices — as well as powering iPads, Apple Watches, AirPods, and other small electronics. It also supports multiple fast-charging protocols, including PD3.0, QC3.0, AFC, SCP, FCP, and PPS, ensuring broad compatibility for a wide range of devices.

Compact and Portable Design: The PicoGo AN13 is significantly smaller than other chargers of the same power—about 27% smaller for the US version and 47% smaller for the EU version. It also features a foldable plug (US version) for easy storage in pockets or bags, making it perfect for daily commutes, travel, and on-the-go use.

Temperature Control Technology: Using Baseus’ proprietary BCT 2.0 temperature control system with lower heat vents and graphene material, the PicoGo AN13 ensures that your charger stays cool, even during extended use.

PicoGo AE21 Digital Display Fast Charger 2C+1A 100W

Fast Charging for Multiple Devices: Armed with dual 100W USB-C ports and a 22.5W USB-A port, the PicoGo AE21 supports seamless fast charging across all three ports. This rapid and efficient power supply is enough to charge a high-powered laptop, smartphone, and pair of AirPods at the same time.

Compact and Portable Design: The PicoGo AE21 is among the smallest 100W three-port chargers available, featuring a foldable plug for both US and EU versions. Its ultra-compact build makes it perfect for travel and effortless storage.

Safer Charging: The PicoGo AE21 uses reliable GaN chips and core components from trusted international manufacturers to ensure safe and compatible charging. It offers the prevention of overcharging, while TUV Rheinland certification guarantees the highest safety standards.

Smart Digital Display: Always stay in control with real-time charging insights. The PicoGo AE21 clearly shows total output power, single-port power, and temperature control mode, so you know exactly how your devices are charging. With voltage and current data at a glance, you can charge smarter, safer, and with complete peace of mind.

Temperature Control Technology: The PicoGo AE21 uses Baseus’ proprietary BCT 2.0 temperature control system with lower heat vents and graphene materials to keep your charger cooler for longer, providing full-process low-temperature protection.

PicoGo AM31 Magnetic Power Bank 5,000mAh 20W Qi2

Compact & Stylish: Ultra-compact aluminum alloy shell with a silicone matte finish for an anti-slip, fingerprint-resistant touch. Its ergonomic curved body makes it easy to hold phone and power bank together, offering a truly portable charging solution.

Everyday Fast Power: 5,000mAh capacity paired with 15W Qi2 wireless charging and 20W USB-C wired output — ideal for quick top-ups on the go. The 11N strong magnet ensures precise, secure attachment for stable charging.

Smart Cooling & Safety: Triple-layer cooling with graphene heat dissipation, aluminum housing, and intelligent temperature control ensures safe, efficient charging at all times.

Built-in Stand: Integrated kickstand supports both portrait and landscape viewing, letting you stay powered while watching content or working hands-free.

Dual-Mode Flexibility: Supports both wireless and wired charging simultaneously, powering up two devices at once.

Broad Compatibility: Works seamlessly with iPhone 12–17 series, Galaxy devices, iPads, Switch, DJI, GoPro, and other USB-C electronics.

PicoGo AM61 Magnetic Power Bank 10,000mAh 45W Qi2.2 (Built-in USB-C Cable)

Qi2.2 Fast Wireless Charging: The AM61 supports the latest Qi2.2 standard, delivering up to 25W wireless power — 67% faster than Qi2 for next-level speed.

3-in-1 High-Power Design: Equipped with a built-in USB-C cable, USB-C port, and wireless pad, the AM61 provides up to 45W wired output, powerful enough to charge iPhones, tablets, and even laptops simultaneously.

Safe and Efficient: Advanced graphene heat management and intelligent temperature control ensure cooler, more reliable charging.

Magnetic Precision & Premium Build: Featuring Magnetic Power Profile (MPP) alignment with ≤0.5mm accuracy and 16 strong N52H magnets, the AM61 ensures secure attachment and improved efficiency. Finished with a high-gloss shell for a sleek, durable look.

PicoGo AF21 Foldable 3-in-1 Magnetic Wireless Charger 35W Qi2.2

Next-Gen Qi2.2 Speed: Delivering up to 25W wireless output, AF21 charges an iPhone 16 Pro to 44% in just 30 minutes (compared to 32% with Qi2).

All-in-One Apple Charging: A compact station that powers iPhone, AirPods, and Apple Watch at once — with Apple Watch S10 reaching 62% in only 30 minutes.

Compact & Travel-Ready: Roughly the size of a deck of cards, AF21 folds for portability and angle adjustment, making it perfect for desks, nightstands, or on the go.

Magnetic Precision & StandBy Support: MagSafe-compatible auto-alignment ensures stable charging, while foldable stand mode unlocks Apple StandBy features for time, widgets, and photos.

Flexible and Safe: Adjustable panels (0–115° for phone, 180° for watch) plus airflow vents keep devices cool with Qi2.2-certified temperature control.

PicoGo AM52 Ultra-Slim Magnetic Power Bank 10,000mAh 45W Qi2.2

Qi2.2 Wireless Charging: Supports up to 25W wireless output — 67% faster than Qi2 — for faster, more efficient power.

45W USB-C Fast Charging: Provides high-speed wired charging for iPhones, tablets, and laptops, with dual charging supported via USB-C and wireless simultaneously.

Slim & Premium Design: Built with an aluminum alloy shell and silicone matte coating for an anti-slip, fingerprint-resistant finish. The slim curved body makes it easy and comfortable to hold your phone and power bank together.

Safe, Smart, and Magnetic: Graphene cooling, intelligent temperature control, and 16 N52H magnets with MPP alignment deliver safe, efficient, and stable charging every time.

The Baseus PicoGo II Series is built for the modern dynamic lifestyle and fits effortlessly in pockets, solving cable clutter, overheating issues, and slow charging constraints. Baseus understands that your charger needs to adapt to your fast-paced routine. This new range ensures snappy power whether wired or wireless, keeping you fully juiced up in no time. Baseus is thrilled to introduce you to a new world of charging freedom, where innovation and excellence can coexist seamlessly.

Availability

The Baseus PicoGo II Series will roll out in phases to meet the needs of global users:

Available Now on Amazon:

PicoGo AE11 Fast Charger 67W: customers can enjoy the best price of  $23.99 with the code “QXHMN9SZ”.

PicoGo AN13 Fast Charger 45W: customers can enjoy the best price of  $17.49 with the code “Y32U2OOR”.

PicoGo AM31 Magnetic Power Bank 5,000mAh: customers can enjoy the best price of  $37.49 with the code “NQXAD3EZ”.

About Baseus

Founded in 2011, Baseus was born out of utmost care for users. The company embodies its slogan: Practical. Reliable. Base on User. This shows the pursuit of ultimate practicality to solve users’ problems with outstanding design and fashionable appearances that also reflect reliability, high quality, and cost-effectiveness. Baseus delivers a variety of products – including Portable Chargers, Desktop Chargers, Wall Chargers, Wireless Earbuds, and Docking Stations. Chosen by 300 million users and providing 6 billion services, Baseus delivers over 100 million practical and aesthetic products each year, continuously enhancing users’ sense of fulfillment. Join the Baseus family today to see a new world of technological innovation.

Media Contact:
Name: Baseus PR Team
Phone: +1 (213) 512-7063
Email: pr@baseus.com
Baseus Technology (HK) Co., Ltd
Baseus Official Website: https://www.baseus.com/

TORRAS Launches Q3 Air for the New iPhone 17 Series

LOS ANGELES, Sept. 10, 2025 /PRNewswire/ — With the world celebrating the debut of the iPhone 17 series, TORRAS introduces the Q3 Air, its most innovative phone case yet. More than protection, it’s a companion for every journey—whether hiking, camping, traveling, or working on the go.

TORRAS Q3 Air for iPhone 17 Series
TORRAS Q3 Air for iPhone 17 Series

Designed for Life, Not Just Devices

The Q3 Air combines the TORRAS AIR PRO-TECH airbag, a feather-light 2.8 mm profile, and an anti-slip dot-matrix texture to keep your iPhone secure in any setting. From mountain trails to seaside barbecues, accidental drops or messy hands no longer threaten your device. The anti-smudge coating, raised bezels, and scratch resistance preserve both screen and camera clarity.

Built-In Freedom

With its 360° aerospace aluminum stand and N52 Halbach magnet array, the Q3 Air enables seamless MagSafe charging, video calls, or movie nights at the campsite. It transforms moments: a desk becomes a workstation, a campfire becomes a cinema, and a festival becomes a gallery of memories.

Everyday Confidence

From quiet mornings at home to crowded festivals, Q3 Air protects without distraction. Smart design touches—precision-engineered metal buttons, anti-fingerprint finish, and magnetic stability—ensure users capture every moment with ease.

TORRAS Philosophy

Since 2012, TORRAS has focused on blending aesthetics, protection, and human-centered innovation. With presence in 40+ countries, its products inspire millions to live boldly. The Q3 Air represents this vision: a case for climbers, dreamers, and everyday adventurers alike.

Perfectly Timed with iPhone 17

Crafted in anticipation of Apple’s latest release, the Q3 Air complements the sleek curves of the iPhone 17 series and pairs effortlessly with Apple’s accessory ecosystem. As millions unbox their devices, TORRAS ensures their first choice of protection reflects both personality and spirit.

Availability

The TORRAS Q3 Air for iPhone 17 is available now at the store.

TORRAS Official Website and Amazon Storefront

Every purchase includes a 365-day worry-free warranty, offering not just protection but peace of mind.